Pages that link to "Q43705623"
Jump to navigation
Jump to search
The following pages link to Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss (Q43705623):
Displaying 50 items.
- Hormone therapy for preventing cardiovascular disease in post-menopausal women (Q24187326) (← links)
- Vitamin D supplementation for prevention of cancer in adults (Q24193850) (← links)
- Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men (Q24195077) (← links)
- Interventions for preventing falls in older people living in the community (Q24200464) (← links)
- Vitamin D supplementation for prevention of mortality in adults (Q24201160) (← links)
- Vitamin D supplementation for prevention of mortality in adults (Q24235390) (← links)
- Interventions for preventing falls in older people living in the community (Q24241432) (← links)
- Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis (Q24241482) (← links)
- Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis (Q24246639) (← links)
- Hormone replacement therapy and prevention of vertebral fractures: a meta-analysis of randomised trials (Q24795111) (← links)
- Treatment of osteoporosis with eldecalcitol, a new vitamin D analog: a comprehensive review and meta-analysis of randomized clinical trials (Q26766549) (← links)
- Controversies in osteoporosis management: antiresorptive therapy for preventing bone loss: when to use one or two antiresorptive agents? (Q27026510) (← links)
- Vitamin D and bone health: potential mechanisms. (Q27690804) (← links)
- Vitamin D treatment for the prevention of falls in older adults: systematic review and meta-analysis (Q33616716) (← links)
- Mechanisms and significance of nuclear receptor auto- and cross-regulation (Q34026116) (← links)
- Prevention and treatment of postmenopausal osteoporosis (Q34296614) (← links)
- Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis (Q34328229) (← links)
- Incidence of hypercalciuria and hypercalcemia during vitamin D and calcium supplementation in older women (Q34403027) (← links)
- Vitamin D supplementation and body weight status: a systematic review and meta-analysis of randomized controlled trials (Q34404297) (← links)
- Superiority of alfacalcidol compared to vitamin D plus calcium in lumbar bone mineral density in postmenopausal osteoporosis (Q34466857) (← links)
- Relationship between vitamin D, parathyroid hormone, and bone health. (Q34617144) (← links)
- Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. (Q34659177) (← links)
- Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis (Q34704488) (← links)
- The efficacy of calcitriol therapy in the management of bone loss and fractures: a qualitative review (Q34718153) (← links)
- Role of the vitamin D-endocrine system in the pathophysiology of postmenopausal osteoporosis (Q35042159) (← links)
- Estrogen receptor-dependent proteasomal degradation of the glucocorticoid receptor is coupled to an increase in mdm2 protein expression (Q35169767) (← links)
- Effect of hormone therapy and calcitriol on serum lipid profile in postmenopausal older women: association with estrogen receptor-α genotypes. (Q35243693) (← links)
- Relation of sex and estrogen therapy to serum fibroblast growth factor 23, serum phosphorus, and urine phosphorus: the Heart and Soul Study (Q35421211) (← links)
- Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate (Q35636715) (← links)
- Independent and combined effects of exercise and vitamin D on muscle morphology, function and falls in the elderly (Q35671089) (← links)
- Falls are associated with decreased renal function and insufficient calcitriol production by the kidney (Q35793029) (← links)
- Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcidol (Q35825912) (← links)
- An age-related decrease in creatinine clearance is associated with an increase in number of falls in untreated women but not in women receiving calcitriol treatment (Q35842590) (← links)
- Treatment with hormone therapy and calcitriol did not affect depression in older postmenopausal women: no interaction with estrogen and vitamin D receptor genotype polymorphisms (Q35870146) (← links)
- Management of vitamin d depletion in postmenopausal women (Q36203238) (← links)
- How to select the doses of vitamin D in the management of osteoporosis (Q36676116) (← links)
- Vitamin D reduces falls and hip fractures in vascular Parkinsonism but not in Parkinson's disease (Q36803644) (← links)
- Comparison of cost-effectiveness of vitamin D screening with that of universal supplementation in preventing falls in community-dwelling older adults (Q36849885) (← links)
- Improving the outcome of established therapies for osteoporosis by adding the active D-hormone analog alfacalcidol (Q36898766) (← links)
- The effect of vitamin D supplementation on serum 25(OH)D in thin and obese women (Q36940982) (← links)
- Additive benefit of higher testosterone levels and vitamin D plus calcium supplementation in regard to fall risk reduction among older men and women (Q37188191) (← links)
- Eldecalcitol for the treatment of osteoporosis (Q37215918) (← links)
- Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls (Q37315523) (← links)
- Influence of estrogen therapy on calcium, phosphorus, and other regulatory hormones in postmenopausal women: the MESA study (Q37361808) (← links)
- Do dietary supplements have beneficial health effects in industrialized nations: what is the evidence? (Q37978591) (← links)
- Prevention of falls in the elderly--a review. (Q38072359) (← links)
- Prevention of falls in the elderly: a review (Q38095909) (← links)
- Questioning vitamin D status of elderly fallers and nonfallers: a meta-analysis to address a 'forgotten step'. (Q38201809) (← links)
- The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IO (Q38452740) (← links)
- Vitamin D and falls - the dosage conundrum (Q38919579) (← links)